Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 572-577

  Kaya, Mitsunori ^a   Wada, Takuro ^a   Akatsuka, Tomohiro ^a   Kawaguchi, Satoshi ^a   Nagoya, Satoshi ^a   Shindoh, Masanobu ^b   Higashino, Fumihiro ^b   Mezawa, Fumie ^b   Okada, Futoshi ^c   Ishii, Seiichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; MICROVASCULATURE; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BONE NEOPLASMS; CHILD; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18844467502     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wada, T., Isu, K., Takeda, N., Usui, M., Ishii, S., and Yamawaki, S. A preliminary report of neoadjuvant chemotherapy NSH-7 study in osteosarcoma: preoperative salvage chemotherapy based on clinical tumor response and the use of granulocyte colony-stimulating factor. Oncology, 53: 221-227, 1996.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
3. Blood, C. H., and Zetter, B. R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta, 1032: 89-118, 1990.
4. Gospodarowicz, D., Abraham, J. A., and Schilling, J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived follicles stellate cells. Proc, Natl. Acad. Sci. USA, 86: 7311-7315, 1989.
5. Ferrara, N., and Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161: 851-858, 1989.
6. De Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255: 989-991, 1992.
7. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family. Oncogene, 5: 519-524, 1990.
8. Maeda, H., Chung, Y., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., and Sowa, M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer (Phila.), 77: 858-863, 1996.
9. Ishigami, S. I., Arii, S., Niwano, M., Harada, T., Mizumoto, M., Mori, A., Onodera, H., and Imamura, M. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br. J. Cancer, 78: 1379-1384, 1998.
10. Inoue, K., Ozeki, Y., Suganuma, T., Sugiura, Y., and Tanaka, S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer (Phila.), 79: 206-213, 1997.
11. Asai, T., Ueda, T., Itoh, K., Yoshioka, K., Aoki, Y., Mori, S., and Yoshikawa, H. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int. J. Cancer, 76: 418-422, 1998.
12. Rosen, G., Huvos, A. G., Marcove, R. C., and Nirenberg, A., Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy. Clin. Orthop., 207: 164-173, 1986.
13. Shindoh, M., Higashino, F., Kaya, M., Yasuda, M., Funaoka, K., Hanzawa, M., Hida, K., Kohgo, T., Amemiya, A., Yoshida, K., and Fujinaga, K. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous cell carcinoma-derived cell lines. Am. J. Pathol., 148: 693-700, 1996.
14. Bettencourt, M. C., Bauer, J. J., Sesterhenn, I. A., Connelly, R. R., and Moul, J. W. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. J. Urol., 160: 459-465, 1998.
15. Unni, K. K. Osteosarcoma. In: Dahkin's Bone Tumors: General Aspects and Data on 11087 Cases, Ed. 5, pp. 143-184. Philadelphia: Lippincott-Raven Publishers, 1996.
16. Enneking, W. F., Spanier, S. S., and Goodman, M. A. A system for the surgical staging of musculoskeletal sarcoma. Clin. Orthop., 153: 106-120, 1980.
17. The JOA Musculo-Skeletal Tumor Committee. General Rules for Clinical and Pathological Studies on Malignant Bone Tumors, Ed. 2. Tokyo: Kanabara, 1990.
18. Garzetti, G. G., Ciavatti, A., Lucarini, G., Pugnaloni, A., De Nictolis, M., Amati, S., Romanii, C., and Biagini, G. Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors. Cancer (Phila.), 85: 2219-2225, 1999.
19. Jinno, K., Tanimizu, M., Hyodo, I., Nishikawa, Y., Hosokawa, Y., Doi, T., Endo, H., Yamashita, T., and Okada, Y. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma. J. Gastroenterol., 33: 376-382, 1998.
20. Brown, L. F., Berse, B., Jackmon, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinoma of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
21. Kawauchi, S., Fukuda, T., and Tsuneyoshi, M. Angiogenesis does not correlate with prognosis or expression of vascular endothelial growth factor in synovial sarcoma. Oncol. Rep., 6: 959-964, 1999.
22. Nagy, J. A., Brown, L. F., Senger, D. R., Lanir, N., Van De Water, L., Dvorak, A. M., and Dvorak, H. F. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta., 948: 305-326, 1989.
23. Winkler, K., Beron, G., Delling, G., Heise, U., Kabisch, H., Purfurst, C., Berger, J., Ritter, J., Jurgens, H., Gerein, V., Graf, N., Russe, W., Gruemayer, E. R., Ertelt, W., Kotz, R., Preusser, P., Pindull, G., Brandeis, W., and Landbeck, G. Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J. Clin. Oncol., 6: 329-337, 1988.
24. Bacci, G., Picci, P., Ruggieri, P., Merucuri, M., Avella, M., Capanna, R., Brach, Del Prever, A., Mancini, A., Gherlinzoni, F., Padovani, G., Leonessa, C., Biagini, R., Ferraro, A., Ferruzzi, A., Cazzola, A., Manfrini, M., and Campanacci, M. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. Cancer (Phila.), 65: 2539-2553, 1990.
25. Glasser, D. B., Lane, J. M., Huvos, A. G., Marcove, R. C., and Rosen, G. Survival, prognosis and therapeutic response in osteogenic sarcoma: the Memorial Hospital Experience. Cancer (Phila.), 69: 698-708, 1992.
26. Souhami, R. L., Craft, A/W., Van der Eijken, J. W., Nooij, M., Spooner, D., Bramwell, V. H. C., Wiezbicki, R., Malcolm, A. J., Kirkpatrick, A., Uscinska, B. M., Van Glabbeke, M., Machin, D. Randomized trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European osteosarcoma intergroup. Lancet, 350: 911-917, 1997.
27. Mori, S., Ueda, Y., Kuratsu, S., Hosono, N., Izawa, K., and Uchida, A. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma. Int. J. Cancer, 61: 148-152, 1995.
28. Morisita, T., Mii, Y., Mitauchi, Y., Miura, S., Honoki, K., Aoki, M., Kido, A., Tamai, S., Tsutsumi, M., Konishi, Y., Efficiency of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (AGM-1470) on osteosarcoma growth and lung metastasis in rats. Jpn. J. Clin. Oncol. 25: 25-31, 1995.